By specifically knocking down expression of two iron metabolic genes, FPN and LCN2, with the DMP-controlled CRISPR/Cas13a and microRNA (miRNA) in cancer cells, the FeNP treatment induced dramatic ferroptosis in a wide variety of cancer cells that represent various hematological and solid tumors. The gene discussed is LCN2; the disease is cancer.